Oral Solid Dosage: The Quiet Strength in the Pharma Industry

17 November 2021 - 17 November 2021
Oral Solid Dosage: The Quiet Strength in the Pharma Industry There is a lot of press coverage regarding new and innovative technologies, from vaccine production to cell therapy, however oral solid dosage (OSD) remains one of the most effective means...
ISPE Online Training

ATMP Manufacturing Training Course T64

This course is focused on the commercial manufacture of Advanced Therapy Medicinal Products (ATMPs) drug products in manufacturing facilities. The purpose of this course is to focus on facility engineering issues and how to provide cost-effective facilities to ensure that products of the highest....

Novedades en Regulación Sanitaria

14 October 2021 - 14 October 2021
Registrate aquí
ISPE Online Training

Critical Utility GMP Compliance (T65)

This course is focused on how to be compliant in the design, operation & qualification of critical utilities and how to prove it. It comprises four modules including interactive case studies from real experience. This helps the participants to experience live discussions on compliance topics. The....
Agility & Innovations in Process Development and Manufacturing
iSpeak Blog
Agility & Innovations in Process Development and Manufacturing

The needs of patients must always be at the forefront of what we do.

Many of our colleagues are taking on the challenge of rethinking the old ways. They are collaborating with each other and the regulatory agencies to take effective steps to remain at the forefront of regulatory science and innovation. Why? In order to ensure the continued delivery of effective medicines.

GAMP Good Practice Guides

GAMP Good Practice Guide: Enabling Innovation

The drive within life sciences to improve patient safety and product quality, and provide value to society, while reducing costs requires constant and effective innovation. However, because the pharmaceutical industry operates in a highly regulated sector, some practitioners may apply unthinking, prescriptive, and rigid approaches that are not commensurate to the needs of the process, the nature of the system, and the real risk to the product and the patient.

Women in Pharma "Walk and Talk"

14 October 2021 - 14 October 2021
Women in Pharma "Walk and Talk" Join fellow members of the ISPE Delaware Valley Chapter for our first “Walk and Talk” event at the historic Valley Forge National Park. Attendees will spend an hour or so walking the nearby trails at their pace, while...
ISPE Member Spotlight: Andria Thomas
iSpeak Blog
ISPE Member Spotlight: Andria Thomas

The San Francisco Bay Area Chapter has won numerous ISPE Awards by virtue of their contributions to the pharmaceutical industry. They continue to have their finger on the pulse of the local industry and respond with innovative and educational programs. The Chapter’s Emerging Leaders Committee is...

Subscribe to